| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 6 2407-2416, Copyright © 1994 by American Association of Immunologists
ARTICLES |
FM Karlhofer, R Hunziker, A Reichlin, DH Margulies and WM Yokoyama
Rosalind Russell Arthritis Research Laboratory, Department of Medicine, University of California, San Francisco 94110.
Target cell expression of certain MHC class I molecules correlates with resistance to lysis by NK cells. To explain this correlation, one hypothesis states that NK cells may possess two types of receptors; one may activate NK cells whereas another, specific for target cell MHC class I molecules, may inhibit natural killing by transducing negative signals. The cell surface molecule, Ly-49, is expressed on an NK cell subpopulation (15% to 20%) in spleens from C57BL/6 (H-2b) mice. Previously, we showed that lysis by Ly-49+ IL-2-activated NK cells was globally inhibited when targets expressed either H-2Dd or an H-2k-class I molecule, consistent with the hypothesis that Ly-49 is an inhibitory NK cell receptor that engages these MHC class I molecules. We now have determined the influence of specific host MHC class I molecules on Ly- 49 expression. In two-color flow cytometric examination of splenic cells, Ly-49+ NK1.1+ cells were undetectable in MHC-congenic strains expressing Dd or Dk, in C57BL/6 mice transgenic for membrane-bound Dd, and in B10.D2dm1 mice. These data establish that Dd itself is sufficient for this effect and suggest that Ly-49 engages Dd-alpha 1/alpha 2 domains. Cross-linking of Ly-49 with membrane-bound Dd may be required because Ly-49+ NK1.1+ cells were readily detectable in C57BL/6 strains transgenic for soluble forms of Dd. To examine whether this effect could be the result of down-regulation of Ly-49 expression or negative selection of Ly-49+ cells, we determined Ly-49 expression on highly purified, freshly isolated NK cell populations (> 90% NK1.1+ CD3- cells). These experiments demonstrated that Ly-49+ cells were present in normal numbers but that Ly-49 expression was markedly decreased in congenic mice expressing H-2Dd or Dk, and in the strain transgenic for membrane-bound H-2Dd. Thus, expression of a putative MHC class I- specific NK cell receptor is modulated by its apparent interaction with alpha 1/alpha 2 domains of host MHC class I molecules.
This article has been cited by other articles:
|
|
 |
|
  N. C. Fernandez, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules Blood, June 1, 2005; 105(11): 4416 - 4423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zimmer, V. Ioannidis, and W. Held H-2D Ligand Expression by Ly49A+ Natural Killer (NK) Cells Precludes Ligand Uptake from Environmental Cells: Implications for NK Cell Function J. Exp. Med., November 19, 2001; 194(10): 1531 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Matsumoto, K. Tajima, M. Mitsuki, and K. Yamamoto H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetramer Int. Immunol., May 1, 2001; 13(5): 615 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Van Beneden, F. Stevenaert, A. De Creus, V. Debacker, J. De Boever, J. Plum, and G. Leclercq Expression of Ly49E and CD94/NKG2 on Fetal and Adult NK Cells J. Immunol., April 1, 2001; 166(7): 4302 - 4311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Matsumoto, W. M. Yokoyama, S. Kojima, and K. Yamamoto The NK Cell MHC Class I Receptor Ly49A Detects Mutations on H-2Dd Inside and Outside of the Peptide Binding Groove J. Immunol., April 1, 2001; 166(7): 4422 - 4428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Tanamachi, T. Hanke, H. Takizawa, A. M. Jamieson, and D. H. Raulet Expression of Natural Killer Receptor Alleles at Different Ly49 Loci Occurs Independently and Is Regulated by Major Histocompatibility Complex Class I Molecules J. Exp. Med., January 29, 2001; 193(3): 307 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Matsumoto, M. Mitsuki, K. Tajima, W. M. Yokoyama, and K. Yamamoto The Functional Binding Site for the C-type Lectin-like Natural Killer Cell Receptor Ly49A Spans Three Domains of Its Major Histocompatibility Complex Class I Ligand J. Exp. Med., January 8, 2001; 193(2): 147 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, K. Natarajan, L. F. Boyd, J. Tormo, R. A. Mariuzza, W. M. Yokoyama, and D. H. Margulies Mapping the Ligand of the NK Inhibitory Receptor Ly49A on Living Cells J. Immunol., December 15, 2000; 165(12): 6922 - 6932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ochi and T. Watanabe Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity Int. Immunol., October 1, 2000; 12(10): 1417 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kusunoki, S. Kyoizumi, M. Honma, Y. Kubo, H. Ohnishi, T. Hayashi, and T. Seyama NK-Mediated Elimination of Mutant Lymphocytes that Have Lost Expression of MHC Class I Molecules J. Immunol., October 1, 2000; 165(7): 3555 - 3563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raziuddin, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, D. L. Longo, and W. J. Murphy Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2b bone marrow cell allografts Blood, June 15, 2000; 95(12): 3840 - 3844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Korten, E. Wilk, J. E. Gessner, D. Meyer, and R. E. Schmidt Altered Donor and Recipient Ly49+ NK Cell Subsets in Allogeneic H-2d -> H-2b and H-2b -> H-2d Bone Marrow Chimeras J. Immunol., December 1, 1999; 163(11): 5896 - 5905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, J. Dorfman, D. Plaksin, K. Natarajan, I. M. Belyakov, R. Hunziker, J. A. Berzofsky, W. M. Yokoyama, M. G. Mage, and D. H. Margulies NK and CTL Recognition of a Single Chain H-2Dd Molecule: Distinct Sites of H-2Dd Interact with NK and TCR J. Immunol., October 1, 1999; 163(7): 3699 - 3708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Depatie, A. Chalifour, C. Pare, S.-H. Lee, S. M. Vidal, and S. Lemieux3 Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets Int. Immunol., September 1, 1999; 11(9): 1541 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Manilay, G. L. Waneck, and M. Sykes Levels of Ly-49 Receptor Expression Are Determined by the Frequency of Interactions with MHC Ligands: Evidence Against Receptor Calibration to a ""Useful"" Level J. Immunol., September 1, 1999; 163(5): 2628 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y. Olsson-Alheim, J. Sundback, K. Karre, and C. L. Sentman The MHC Class I Molecule H-2Dp Inhibits Murine NK Cells via the Inhibitory Receptor Ly49A J. Immunol., June 15, 1999; 162(12): 7010 - 7014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Idris, K. Iizuka, H. R.C. Smith, A. A. Scalzo, and W. M. Yokoyama Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus J. Exp. Med., December 21, 1998; 188(12): 2243 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Andersson, S. Freland, M. H. Johansson, R. Wallin, J. K. Sandberg, B. J. Chambers, B. Christensson, U. Lendahl, S. Lemieux, M. Salcedo, et al. MHC Class I Mosaic Mice Reveal Insights into Control of Ly49C Inhibitory Receptor Expression in NK Cells J. Immunol., December 15, 1998; 161(12): 6475 - 6479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kase, M. H. Johansson, M. Y. Olsson-Alheim, K. Karre, and P. Hoglund External and Internal Calibration of the MHC Class I-Specific Receptor Ly49A on Murine Natural Killer Cells J. Immunol., December 1, 1998; 161(11): 6133 - 6138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Manoussaka, R. J. Smith, V. Conlin, J. A. Toomey, and C. G. Brooks Fetal Mouse NK Cell Clones Are Deficient in Ly49 Expression, Share a Common Broad Lytic Specificity, and Undergo Continuous and Extensive Diversification In Vitro J. Immunol., March 1, 1998; 160(5): 2197 - 2206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raziuddin, D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, and W. J. Murphy Differential Effects of the Rejection of Bone Marrow Allografts by the Depletion of Activating Versus Inhibiting Ly-49 Natural Killer Cell Subsets J. Immunol., January 1, 1998; 160(1): 87 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Naper, J. C. Ryan, M. C. Nakamura, D. Lambracht, B. Rolstad, and J. T. Vaage Identification of an Inhibitory MHC Receptor on Alloreactive Rat Natural Killer Cells J. Immunol., January 1, 1998; 160(1): 219 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Johansson, C. Bieberich, G. Jay, K. Karre, and P. Hoglund Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene J. Exp. Med., August 4, 1997; 186(3): 353 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Held and D. H. Raulet Ly49A Transgenic Mice Provide Evidence for a Major Histocompatibility Complex-dependent Education Process in Natural Killer Cell Development J. Exp. Med., June 16, 1997; 185(12): 2079 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Brennan, S. Lemieux, J. D. Freeman, D. L. Mager, and F. Takei Heterogeneity Among Ly-49C Natural Killer (NK) Cells: Characterization of Highly Related Receptors with Differing Functions and Expression Patterns J. Exp. Med., December 15, 1996; 184(6): 2085 - 2090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Karre Express yourself or die: peptides, MHC molecules, and NK cells Science, February 17, 1995; 267(5200): 978 - 979. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
